Home › Funds › DC Funds, LP › HOWL
DC Funds, LP position in HOWL
WEREWOLF THERAPEUTICS INC · Health Care
DC Funds, LP reported holding 589,102 shares of HOWL (WEREWOLF THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$543.3M, representing 73.28% of its reported portfolio and ranking #1 among its reported holdings. DC Funds, LP has disclosed HOWL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How DC Funds, LP's HOWL position evolved
DC Funds, LP first disclosed a stake in HOWL in Q3 2023 at 589,102 shares (US$1.3M). The position peaked in Q1 2025 at 589,102 shares, worth US$572.7M. Across 13 filings, DC Funds, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 589,102 shares valued at US$543.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 589.10K | $1.26M | New |
| Q4 2023 | 589.10K | $2.27M | Hold |
| Q1 2024 | 589.10K | $3.82M | Hold |
| Q2 2024 | 589.10K | $1.44M | Hold |
| Q3 2024 | 589.10K | $1.25M | Hold |
| Q4 2024 | 589.10K | $871.87K | Hold |
| Q1 2025 | 589.10K | $572.73M | Hold |
| Q2 2025 | 589.10K | $642.12K | Hold |
| Q3 2025 | 589.10K | $1.16M | Hold |
| Q4 2025 | 589.10K | $373.20M | Hold |
| Q1 2026 | 589.10K | $490.49M | Hold |
| Q2 2026 | 589.10K | $212.02M | Hold |
| Q3 2026 | 589.10K | $543.33M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HOWL and 13F data
HOWL (WEREWOLF THERAPEUTICS INC) is a Health Care company. 16 other funds we track also report a position in HOWL — the largest reported positions include Lynx1 Capital Management LP (US$237K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HOWL
- Lynx1 Capital Management LP 657.79K sh · $236.74K · Q2 2026
FAQ
How long has DC Funds, LP held HOWL?
DC Funds, LP has disclosed HOWL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is DC Funds, LP's current position in HOWL?
As of Q3 2026, DC Funds, LP holds 589.10K shares of HOWL (WEREWOLF THERAPEUTICS INC), valued at $543.33M, representing 73.28% of its reported portfolio and ranking #1.
Has DC Funds, LP been buying or selling HOWL?
In the latest 13F filing (Q3 2026), DC Funds, LP held unchanged its position in HOWL. The position peaked in Q1 2025 at 589.10K shares.
Which other funds hold HOWL?
Other major institutional holders of HOWL include Lynx1 Capital Management LP, among 16 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.